Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
for Newly Diagnosed Multiple Myeloma
Sites in Wichita +43 more locations
Sponsor: AstraZeneca
Sex: All·Age: 18+
Code: NCT07764978·Phase 3·Recruiting·Listed Aug 14, 2026
Paid Clinical Trials in Wichita, KS
As of September 2026, 124 paid clinical trials are recruiting in Wichita, Kansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Wichita offers studies at sites including Ascension Via Christi Hospitals Wichita for conditions such as Coronary Artery Disease, Hypertension, Obesity, Heart Failure. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Wichita
Trials by drug in Wichita
Filter results
Filter results
Newly added in Wichita
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
121 clinical trials
Get a weekly email when new trials open in Wichita, KS.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
Drug: Elismetrep
Sites in Wichita, Overland Park +111 more locations
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 2026
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
for Obesity
Drug: NNC0487-0111
Sites in Wichita +205 more locations
Sponsor: Novo Nordisk A/S
Sex: All·Age: 18+
Code: NCT07567001·Phase 3·Recruiting·Listed May 2026
A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
for Hypercholesterolaemia
Drug: Inclisiran
Sites in Wichita +28 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 75
Code: NCT07610278·Phase 2·Recruiting·Listed May 2026
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for Chronic Idiopathic Constipation (CIC)
Drug: Tenapanor
Sites in Wichita, Overland Park +107 more locations
Sponsor: Ardelyx
Sex: All·Age: 18 - 80
Code: NCT07382167·Phase 3·Recruiting·Listed Feb 2026
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for Prostatic Neoplasms, Castration-Resistant
Drug: Pasritamig
Sites in Wichita +52 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07225946·Phase 3·Recruiting·Listed Nov 2025
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for Focal Segmental Glomerulosclerosis
Sites in Wichita, Kansas City +71 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 12+
Code: NCT07220083·Phase 3·Recruiting·Listed Oct 2025
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
for Diabetes Mellitus, Type 2
Drug: Empagliflozin
Sites in Wichita, El Dorado +202 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07064473·Phase 3·Recruiting·Listed Jul 2025
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for Breast Cancer
Sites in Wichita +171 more locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06492616·Phase 3·Recruiting·Listed Jul 2024
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
for Crohn Disease
Sites in Wichita +52 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT07196722·Phase 2, Phase 3·Recruiting·Listed Sep 2025
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
for End Stage Kidney Disease
Drug: Clazakizumab
Sites in Wichita +147 more locations
Sponsor: CSL Behring
Sex: All·Age: 18+
Code: NCT05485961·Phase 2, Phase 3·Recruiting·Listed Aug 2022
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
for Symptomatic Venous Thromboembolism (VTE)
Drug: REGN7508
Sites in Wichita +27 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07213778·Phase 3·Recruiting·Listed Oct 2025
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Wichita +67 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06750094·Phase 3·Recruiting·Listed Dec 2024
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for Migraine
Drug: Ubrogepant
Sites in Wichita, Overland Park +84 more locations
Sponsor: AbbVie
Sex: All·Age: 6 - 17
Code: NCT05125302·Phase 3·Recruiting·Listed Nov 2021
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
for Early Breast Cancer
Drug: Ribociclib
Sites in Wichita, Westwood +81 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT05827081·Phase 3·Recruiting·Listed Apr 2023
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
for Heart Failure
Drug: Empagliflozin
Sites in Wichita, Kansas City +84 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06935370·Phase 3·Recruiting·Listed Apr 2025
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for Colorectal Neoplasms
Drug: Amivantamab
Sites in Wichita +80 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06662786·Phase 3·Recruiting·Listed Oct 2024
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
for Advanced Non-Small Cell Lung Cancer
Drug: Adagrasib
Sites in Wichita, Newton +190 more locations
Sponsor: Mirati Therapeutics Inc.
Sex: All·Age: 18+
Code: NCT04613596·Phase 2, Phase 3·Recruiting·Listed Nov 2020
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for Neoplasms
Sites in Wichita, Westwood +75 more locations
Sponsor: Celgene
Sex: All·Age: All ages
Code: NCT03435796·Phase 2, Phase 3·Recruiting·Listed Feb 2018
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for Triple Negative Breast Cancer
Sites in Wichita +123 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for PIK3CA Mutation
Sites in Wichita, Westwood +50 more locations
Sponsor: Relay Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06982521·Phase 3·Recruiting·Listed May 2025
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for Heart Failure
Drug: Empagliflozin
Sites in Wichita +93 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06424288·Phase 3·Recruiting·Listed May 2024
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
for Lumbar Spinal Stenosis
Sites in Wichita, Great Bend +2386 more locations
Sponsor: Stryker Instruments
Sex: All·Age: 18+
Code: NCT03072927·Recruiting·Listed Mar 2017
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for High-Risk Non-Muscle-Invasive Bladder Cancer
Sites in Wichita +74 more locations
Sponsor: CG Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06567743·Phase 2·Recruiting·Listed Aug 2024
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
for Alzheimer Disease
Sites in Wichita +37 more locations
Sponsor: Lighthouse Pharmaceuticals, Inc.
Sex: All·Age: 55 - 80
Code: NCT06847321·Phase 2·Recruiting·Listed Feb 2025
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
for Hypertension
Sites in Wichita, Kansas City +54 more locations
Sponsor: Orchestra BioMed, Inc
Sex: All·Age: 18+
Code: NCT06059638·Recruiting·Listed Sep 2023
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
for Small-cell Lung Cancer
Drug: Durvalumab
Sites in Wichita +49 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07005128·Phase 3·Recruiting·Listed Jun 2025
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for Moderately to Severely Active Crohns Disease
Drug: Afimkibart
Sites in Wichita +91 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06819878·Phase 3·Recruiting·Listed Feb 2025
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for Intermediate Risk Non-Muscle Invasive Bladder Cancer
Drug: Nadofaragene Firadenovec
Sites in Wichita +49 more locations
Sponsor: Ferring Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06510374·Phase 3·Recruiting·Listed Jul 2024
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
for Acute Stroke
Sites in Wichita +35 more locations
Sponsor: DiaMedica Therapeutics Inc
Sex: All·Age: 18 - 90
Code: NCT05065216·Phase 2, Phase 3·Recruiting·Listed Oct 2021
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
for Metastatic Castration-resistant Prostate Cancer
Sites in Wichita, Westwood +44 more locations
Sponsor: Celgene
Sex: Male·Age: 18+
Code: NCT06764485·Phase 3·Recruiting·Listed Jan 2025
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve
for Aortic Stenosis, Severe
Sites in Wichita +25 more locations
Sponsor: Edwards Lifesciences
Sex: All·Age: All ages
Code: NCT05172960·Recruiting·Listed Dec 2021
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
for Kidney Disease, Chronic
Drug: Empagliflozin
Sites in Wichita, Kansas City +47 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT06531824·Phase 3·Recruiting·Listed Aug 2024
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for Diabetic Peripheral Neuropathic Pain
Sites in Wichita +58 more locations
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All·Age: 18 - 80
Code: NCT06628908·Phase 3·Recruiting·Listed Oct 2024
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
for Heart Failure With Preserved Ejection Fraction
Sites in Wichita, Lenexa +108 more locations
Sponsor: Amgen
Sex: All·Age: 18 - 99
Code: NCT07037459·Phase 3·Recruiting·Listed Jun 2025
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
for Non-small Cell Lung Cancer
Drug: Relatlimab
Sites in Wichita +39 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT06561386·Phase 3·Recruiting·Listed Aug 2024
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for Moderately to Severely Active Ulcerative Colitis
Drug: Afimkibart
Sites in Wichita +69 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06588855·Phase 3·Recruiting·Listed Sep 2024
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
for High Risk Cardiovascular Disease
Drug: Zilebesiran
Sites in Wichita, Hutchinson +272 more locations
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07181109·Phase 3·Recruiting·Listed Sep 2025
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
for Cancer Weight Loss
Sites in Wichita +24 more locations
Sponsor: Endevica Bio
Sex: All·Age: 18+
Code: NCT06937177·Phase 2·Recruiting·Listed Apr 2025
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
for Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Sites in Wichita +26 more locations
Sponsor: Bayer
Sex: All·Age: All ages
Code: NCT04142437·Recruiting·Listed Oct 2019
SELUTION 4 De Novo Small Vessel IDE Trial
for Coronary Artery Disease
Sites in Wichita +63 more locations
Sponsor: M.A. Med Alliance S.A.
Sex: All·Age: 18+
Code: NCT05946629·Recruiting·Listed Jul 2023
Top Research Study Locations in Wichita
Researchers run research studies in Wichita, KS at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Ascension Via Christi Hospitals Wichita | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 13 |
| Cancer Center of Kansas | Breast Cancer, Colorectal Neoplasms, Advanced Breast Cancer | 10 |
| Cancer Center of Kansas - Wichita | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 9 |
| Cancer Center of Kansas-Wichita Medical Arts Tower | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 8 |
| Wichita Urology Group | Prostate Cancer, High-Risk Non-Muscle-Invasive Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer | 8 |
| Wesley Medical Center | Adrenal Gland Pheochromocytoma, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | 7 |
| Cardiovascular Research Institute of Kansas | Coronary Artery Disease, Acute Myocardial Infarction, Aortic Stenosis | 5 |
| Ascension Via Christi St. Francis | Aortic Stenosis, Aortic Stenosis, Calcific, Aortic Valve Stenosis | 5 |
| Ascension Via Christi Saint Francis | Coronary Artery Disease, Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder) | 3 |
| Kansas Gastroenterology, LLC | Bowel; Stricture, Crohn Disease, Esophageal Stricture | 3 |
| Alliance for Multispecialty Research | Hypercholesterolaemia, Hypertension (HTN) | 2 |
| Heartland Research Associates, LLC - An AMR Company | Acute Migraine, Migraine | 2 |
| Kansas Gastroenterology, LLC under Clinical Trials Network | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Kansas Nephrology Research Institute, LLC | Heart Failure, Kidney Disease, Chronic | 2 |
| Robert J Dole VA Medical Center | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of the Colon | 2 |
| Via Christi Regional Medical Center - St. Francis Campus | Aortic Valve Disease, Aortic Valve Stenosis, Heart Disease Structural Disorder | 2 |
| West Houston Area Clinical Trial Consultants, LLC | Heart Failure | 2 |
| Wichita Urology Group PA | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC), Progressive Metastatic Castrate Resistant Prostate Cancer | 2 |
| Ascension Via Christi Research | Heart Valve Diseases, Tricuspid Regurgitation, Tricuspid Valve Disease | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| ACCOMPLISH-1 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| ACCOMPLISH-2 Research Site | Chronic Weight Management, Obesity, Overweight | 1 |
| AMR Wichita East, KS (Heartland Research Associates) | Diabetic Peripheral Neuropathic Pain | 1 |
| Advanced Pain Medicine Assocs | Lumbar Spinal Stenosis | 1 |
| Alliance For Multispeciality Research - Wichita East | Migraine | 1 |
Active & Upcoming Studies in Wichita (2026)
Recruiting trials in Wichita grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (38 active studies)
- Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT · Phase 3 · AstraZeneca
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
Cardiovascular (22 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients. · Phase 2 · Novartis Pharmaceuticals
Diabetes & metabolic (9 active studies)
- Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION) · Phase 3 · Amgen
- A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2) · Phase 3 · Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Neurology & pain (8 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Eye & vision (1 active study)
- IC-8 Apthera IOL New Enrollment Post Approval Study · Bausch & Lomb Incorporated
Common conditions studied in Wichita
- Coronary Artery Disease (6 active studies)
- Hypertension (5 active studies)
- Obesity (5 active studies)
- Heart Failure (4 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)
- Aortic Valve Stenosis (3 active studies)
Leading research sponsors in Wichita
- AstraZeneca
- Novartis Pharmaceuticals
- Alliance for Clinical Trials in Oncology
- Boehringer Ingelheim
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Wichita?
There are approximately 124 recruiting clinical trials in Wichita, Kansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Wichita pay participants?
Most recruiting trials in Wichita compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Wichita?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Wichita?
The most common conditions under active study in Wichita include Coronary Artery Disease (6), Hypertension (5), Obesity (5), Heart Failure (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Wichita?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Wichita on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Wichita?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Wichita?
Recruiting research sites in Wichita include Ascension Via Christi Hospitals Wichita, Cancer Center of Kansas, Cancer Center of Kansas - Wichita, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Wichita right now?
The largest active categories in Wichita are Cancer & tumors (38), Cardiovascular (22), Diabetes & metabolic (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Kansas
Kansas City, KS(459)Overland Park, KS(160)Westwood, KS(154)Topeka, KS(93)Fairway, KS(78)Lawrence, KS(49)Olathe, KS(44)Salina, KS(40)Hays, KS(37)Pittsburg, KS(30)Lenexa, KS(29)Garden City, KS(28)Great Bend, KS(27)Newton, KS(17)El Dorado, KS(13)Leawood, KS(8)Hutchinson, KS(7)Leavenworth, KS(6)Manhattan, KS(6)Parsons, KS(6)Pratt, KS(6)Chanute, KS(5)Independence, KS(5)Kingman, KS(5)Liberal, KS(5)Prairie Village, KS(5)Wellington, KS(5)Winfield, KS(5)Dodge City, KS(4)McPherson, KS(4)Merriam, KS(4)Shawnee Mission, KS(4)Roeland Park, KS(3)Emporia, KS(2)Colby, KS(1)Derby, KS(1)Garnett, KS(1)Iola, KS(1)Ottawa, KS(1)Overland, KS(1)